Senvion S.A.

  • WKN: A2AFKW
  • ISIN: LU1377527517
  • Land: Großherzogtum Luxemburg

Nachricht vom 11.01.2017 | 11:03

Senvion concludes 33 megawatt contract with Innogy Renewables UK Ltd.


DGAP-Media / 11.01.2017 / 11:03

Senvion concludes 33 megawatt contract with Innogy Renewables UK Ltd.

Hamburg/Edinburgh: Senvion, a leading global manufacturer of wind turbines, has signed a contract with Innogy Renewables UK Ltd. to supply 16 wind turbines from its two megawatts (MW) series for the Mynydd y Gwair wind farm in South Wales.

Located 15 km north of Swansea, Mynydd y Gwair wind farm will consist of 16 Senvion MM92 turbines. Once operational, the project will have an installed capacity of 32.8MW and will generate enough renewable electricity to power more than 22,000 average UK households annually*. Turbine components will start to be delivered to site in April 2018 and installation and commissioning is due to be completed in October 2018.

This is the eleventh contract to be signed between Senvion and Innogy Renewables UK Ltd. and the conclusion of this contract marks the fifth consecutive turbine supply agreement between both parties. In 2016, Senvion concluded agreements to supply turbines for Innogy Renewable UK's Brechfa Forest West wind farm and Bad á Cheò wind farm. Brechfa Forest West wind farm is located in Carmarthenshire, in South Wales. The wind farm will consist 28 MM92 turbines providing an overall capacity of 57.4 megawatts. Grid consent for the project was confirmed in October 2016. Once fully operational, the wind farm will generate enough renewable electricity to meet the calculative needs of approximately 38,800 average UK households annually. Bad á Cheò wind farm is located near Caithness in Scotland and will feature 13 MM92 turbines. Construction will start in early 2017 and once constructed, the wind farm will provide an installed capacity of up to 26.7MW.

Senvion also concluded five year maintenance contracts with Innogy Renewables UK Ltd. for all three projects, with options to extend these up to 10 and then 15 years.

Guy Madgwick, Managing Director of Senvion Northern Europe, said: "We are delighted to be working with innogy Renewables UK once more. Since we signed our first contract together for the Ffynnon Oer wind farm in 2005 we have partnered on a number of successful projects and these additional contracts demonstrate the strength of the established and reliable relationship we have maintained for more than a decade."

Tanya Davies, Head of Onshore Development at Innogy Renewables UK Ltd. said: "It was great to have all contracts signed before the financial year end. We are delighted to see Mynydd y Gwair Wind Farm join Brechfa Forest West and Bad á Cheò and enter into construction. This is great news for the industry and the investment opportunities in South Wales."

Gwenllian Elias, Mynydd y Gwair development manager at Innogy Renewables UK Ltd. said: "We look forward to the construction of Mynydd y Gwair Wind Farm and the Senvion turbines being erected and generating clean renewable energy in the near future."


Footnotes
*It is estimated that the average annual generation expected at the site could be equivalent to the approximate domestic needs of up to 22,600 average UK households. Energy predicted to be generated by the proposal is derived using wind speeds monitored in the local area and correlating to historical reanalysis weather data providing longer term data. The calculations are based on an installed capacity of 32.8 MW. The energy capture predicted and hence derived homes equivalent figure may change as further data are gathered. Equivalent homes supplied is based on an annual electricity consumption per home of 4400 kWh. This figure is supported by recent domestic electricity consumption data available from The Digest of UK Energy Statistics and household figures from the UK Statistics Authority.

About Senvion:
Senvion is a leading global manufacturer of onshore and offshore wind turbines. The company develops, produces and markets wind turbines for almost any location - with rated outputs of 2 MW to 6.15 MW and rotor diameters of 82 metres to 152 metres. Furthermore, the company offers its customers project specific solutions in the areas of turnkey, service and maintenance, transport and installation, as well as foundation planning and construction. The systems are designed at the Senvion TechCenter in Osterrönfeld and manufactured at its German plants in Husum (North Friesland), Trampe (Brandenburg) and Bremerhaven, as well as Portugal. With approximately 4,000 employees worldwide, the company makes use of the experience gained from the manufacture and installation of more than 6,600 wind turbines around the world. The company's operational subsidiary Senvion GmbH is based in Hamburg and represented by distribution partners, subsidiaries and participations in European markets such as France, Belgium, the Netherlands, the UK, Italy, Romania, Portugal, Sweden, and Poland as well as on a global level in the USA, China, Australia and Canada. Senvion S.A. is listed on the Prime Standard of the Frankfurt Stock Exchange.
 

Senvion Press contacts:
Stephanie Oxley
Corporate Communications
Mobile: +44 7534 260 998
E-Mail: stephanie.oxley@senvion.com



Senvion Investor Relations contact:
Dhaval Vakil
Tel: +44 20 7034 7992
Mobil: +44 7788 390 185
E-mail: dhaval.vakil@senvion.com

Marie-Danielle Laggner
Corporate Communications
Tel.: +49 40 5555 0903040
Mobile: +49 172 27 67 793
E-Mail: marie.laggner@senvion.com


End of Media Release


Issuer: Senvion S.A.
Key word(s): Energy

11.01.2017 Dissemination of a Press Release, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

Anleihe im Fokus

EYEMAXX Real Estate AG: EYEMAXX begibt Wandelanleihe im Volumen von bis zu 20,376 Mio. Euro

Kupon:4,5%

Bezugsfrist: bis 12. April 2017 (12.00 Uhr)

Öffentliches Angebot:bis 18. April 2017 (12.00 Uhr)

Laufzeit:bis einschließlich 15. Dezember 2019

ISIN: DE000A2DAJB7

GBC im Fokus

Neovacs S.A.: Kursziel auf 3,30 € angehoben

In den letzten Monaten hatte die Neovacs S.A. einen positiven Newsflow. Im Vordergrund steht die Vertriebspartnerschaft für den chinesischen Markt, wodurch sich bis nach dem ersten Vermarktungsjahr Gesamterträge von bis zu 65 Mio. € ergeben können. Zudem verläuft der klinische Zulassungsprozess des IFNα-Kinoid zur Behandlung von SLE (Systemischer Lupus) und Dermatomyositis planmäßig. Wir haben in unsere Bewertung aktualisiert und ein Kursziel von 3,30 € je Aktie (bisher: 2,90 €) ermittelt. Das Rating lautet weiter KAUFEN.

Event im Fokus

65. m:access Analystenkonferenz

Datum: 06.04.2017
Zeit: 09:30 - 17:00 Uhr
Ort: Börse München
Karolinenplatz 6
80333 München

News im Fokus

Vonovia SE: 93,09 % der conwert-Aktionäre nehmen das Übernahmeangebot von Vonovia an

27. März 2017, 18:18

Aktueller Webcast

Manz AG

Annual Report 2016

30. März 2017

Aktuelle Research-Studie

Ergomed plc

Original-Research: Ergomed plc (von GBC AG): Kaufen

29. März 2017